BACKGROUND: In December, 2007, a family cluster of two individuals infected with highly pathogenic avian influenza A (H5N1) virus was identified in Jiangsu Province, China. Field and laboratory investigations were implemented immediately by public-health authorities. METHODS: Epidemiological, clinical, and virological data were collected and analysed. Respiratory specimens from the patients were tested by reverse transcriptase (RT) PCR and by viral culture for the presence of H5N1 virus. Contacts of cases were monitored for symptoms of illness for 10 days. Any contacts who became ill had respiratory specimens collected for H5N1 testing by RT PCR. Sera were obtained from contacts for H5N1 serological testing by microneutralisation and horse red-blood-cell haemagglutinin inhibition assays. FINDINGS: The 24-year-old index case died, and the second case, his 52-year-old father, survived after receiving early antiviral treatment and post-vaccination plasma from a participant in an H5N1 vaccine trial. The index case's only plausible exposure to H5N1 virus was a poultry market visit 6 days before the onset of illness. The second case had substantial unprotected close exposure to his ill son. 91 contacts with close exposure to one or both cases without adequate protective equipment provided consent for serological investigation. Of these individuals, 78 (86%) received oseltamivir chemoprophylaxis and two had mild illness. Both ill contacts tested negative for H5N1 by RT PCR. All 91 close contacts tested negative for H5N1 antibodies. H5N1 viruses isolated from the two cases were genetically identical except for one non-synonymous nucleotide substitution. INTERPRETATION: Limited, non-sustained person-to-person transmission of H5N1 virus probably occurred in this family cluster.
BACKGROUND: In December, 2007, a family cluster of two individuals infected with highly pathogenic avian influenza A (H5N1) virus was identified in Jiangsu Province, China. Field and laboratory investigations were implemented immediately by public-health authorities. METHODS: Epidemiological, clinical, and virological data were collected and analysed. Respiratory specimens from the patients were tested by reverse transcriptase (RT) PCR and by viral culture for the presence of H5N1 virus. Contacts of cases were monitored for symptoms of illness for 10 days. Any contacts who became ill had respiratory specimens collected for H5N1 testing by RT PCR. Sera were obtained from contacts for H5N1 serological testing by microneutralisation and horse red-blood-cell haemagglutinin inhibition assays. FINDINGS: The 24-year-old index case died, and the second case, his 52-year-old father, survived after receiving early antiviral treatment and post-vaccination plasma from a participant in an H5N1 vaccine trial. The index case's only plausible exposure to H5N1 virus was a poultry market visit 6 days before the onset of illness. The second case had substantial unprotected close exposure to his ill son. 91 contacts with close exposure to one or both cases without adequate protective equipment provided consent for serological investigation. Of these individuals, 78 (86%) received oseltamivir chemoprophylaxis and two had mild illness. Both ill contacts tested negative for H5N1 by RT PCR. All 91 close contacts tested negative for H5N1 antibodies. H5N1 viruses isolated from the two cases were genetically identical except for one non-synonymous nucleotide substitution. INTERPRETATION: Limited, non-sustained person-to-person transmission of H5N1 virus probably occurred in this family cluster.
Authors: Sander Herfst; Eefje J A Schrauwen; Martin Linster; Salin Chutinimitkul; Emmie de Wit; Vincent J Munster; Erin M Sorrell; Theo M Bestebroer; David F Burke; Derek J Smith; Guus F Rimmelzwaan; Albert D M E Osterhaus; Ron A M Fouchier Journal: Science Date: 2012-06-22 Impact factor: 47.728
Authors: Dirk Eggink; Monique Spronken; Roosmarijn van der Woude; Jocynthe Buzink; Frederik Broszeit; Ryan McBride; Hana A Pawestri; Vivi Setiawaty; James C Paulson; Geert-Jan Boons; Ron A M Fouchier; Colin A Russell; Menno D de Jong; Robert P de Vries Journal: J Virol Date: 2020-06-16 Impact factor: 5.103
Authors: Robert P de Vries; Xueyong Zhu; Ryan McBride; Alan Rigter; Anthony Hanson; Gongxun Zhong; Masato Hatta; Rui Xu; Wenli Yu; Yoshihiro Kawaoka; Cornelis A M de Haan; Ian A Wilson; James C Paulson Journal: J Virol Date: 2013-10-30 Impact factor: 5.103
Authors: Benjamin J Cowling; Lianmei Jin; Eric H Y Lau; Qiaohong Liao; Peng Wu; Hui Jiang; Tim K Tsang; Jiandong Zheng; Vicky J Fang; Zhaorui Chang; Michael Y Ni; Qian Zhang; Dennis K M Ip; Jianxing Yu; Yu Li; Liping Wang; Wenxiao Tu; Ling Meng; Joseph T Wu; Huiming Luo; Qun Li; Yuelong Shu; Zhongjie Li; Zijian Feng; Weizhong Yang; Yu Wang; Gabriel M Leung; Hongjie Yu Journal: Lancet Date: 2013-06-24 Impact factor: 79.321
Authors: David A Boltz; Bounlom Douangngeun; Phouvong Phommachanh; Settha Sinthasak; Ricarda Mondry; Caroline Obert; Patrick Seiler; Rachael Keating; Yasuo Suzuki; Hiroaki Hiramatsu; Elena A Govorkova; Robert G Webster Journal: J Gen Virol Date: 2009-12-16 Impact factor: 3.891